Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-280.56M
↓ 160% below average
Average (9y)
$-108.00M
Historical baseline
Range
High:$-9.20M
Low:$-280.56M
CAGR
+46.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-280.56M | -21.0% |
| 2023 | $-231.82M | -28.9% |
| 2022 | $-179.80M | -44.2% |
| 2021 | $-124.71M | -25.8% |
| 2020 | $-99.14M | -47.4% |
| 2019 | $-67.25M | -104.7% |
| 2018 | $-32.85M | -20.9% |
| 2017 | $-27.16M | +1.4% |
| 2016 | $-27.54M | -199.5% |
| 2015 | $-9.20M | - |